Loading clinical trials...
Loading clinical trials...
Comparative Characteristics of Analgesia Methods in the Early Postoperative Period After Coronary Artery Bypass Grafting (CABG)
Conditions
Interventions
Tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amide)
Morphine (+)
Locations
1
Russia
Primorsky Regional General Hospital #1
Vladivostok, Outside US, Russia
Start Date
December 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
March 15, 2026
Last Updated
March 5, 2026
NCT07331558
NCT07060937
NCT06726239
NCT07031128
NCT06645327
NCT06586749
Lead Sponsor
Primorsky Regional General Hospital #1
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions